Pancreatitis complications in a patient with myelodysplastic syndrome, who was treated with fluconazole

International Journal of Clinical Practice

Volumn 58, Issue 8, 2004, Pages 811-

  Tsutsumi, Y ^a   Ehira, N ^a   Kanamori, H ^a   Yamato, H ^a   Obara, S ^a   Tanaka, J ^b   Asaka, M ^b   Imamura, M ^b   Masauzi, N ^a  

^a Hakodate Municipal Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; CYTARABINE; FLUCONAZOLE; NAFAMSTAT MESILATE; PANIPENEM PLUS BETAMIPRON;

ABDOMINAL PAIN; AGED; ALLERGIC REACTION; BONE MARROW BIOPSY; CASE REPORT; DISEASE COURSE; DIZZINESS; DRUG WITHDRAWAL; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; LIVER INJURY; MALE; MYELODYSPLASTIC SYNDROME; NAUSEA; NEPHROTOXICITY; OUTCOMES RESEARCH; PANCREATITIS; PNEUMONIA; PRIORITY JOURNAL;

AGED; ANTIFUNGAL AGENTS; FLUCONAZOLE; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; PANCREATITIS;

EID: 4544340337     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00297.x     Document Type: Letter

References (5)

1. Budtz-Jorgensen E, Holmstrup P, Krogh P. Fluconazole in the treatment of candida-associated denture stomatitis. Antimicrob Agents Chemother 1988; 32: 1859-63.
2. Marr KA, Seidel K, Slavin MA et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000; 96: 2055-61.
3. Aksu G, Ruhi MZ, Akan H et al. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 2001; 27: 201-5.
4. Marr KA. Antifungal prophylaxis in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis 2001; 14: 423-6.
5. Safdar A, van Rhee F, Henslee-Downey JP et al. Candida glabrata and Candida kurusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant 2001; 28: 873-38.